英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
perdere查看　perdere　在百度字典中的解释百度英翻中〔查看〕
perdere查看　perdere　在Google字典中的解释Google英翻中〔查看〕
perdere查看　perdere　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Managing myelofibrosis (MF) that “blasts” through: advancements in the . . .
    SL-401: Recombinant IL-3 with diphtheria toxin: NCT02268253; 70 Sotatercept * ACTRIIa: NCT01712308; 71 our treatment algorithm is the same as in patients who relapsed on ruxolitinib as described above Case 1, continued (Venclexta) has received an FDA breakthrough therapy designation for use in combination with low-dose cytarabine in
  • Venetoclax - Wikipedia
    Venetoclax, sold under the brand names Venclexta and Venclyxto, is a medication used to treat adults with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or acute myeloid leukemia (AML) [7] [8]The most common side effects are low levels of neutrophils (a type of white blood cell), diarrhea, nausea, anemia (low red blood cell counts), nose and throat infection and tiredness
  • Treating Chronic Lymphocytic Leukemia and Small Lymphocytic . . . - WebMD
    Venclexta comes as a tablet in the following doses: 10 milligrams (mg), 50 mg, and 100 mg Venclexta is taken once a day, around the same time each day, with food and water Do not crush, chew, or
  • Venclexta Patient Tips: 7 things you should know - Drugs. com
    Venclexta is a brand (trade) name for venetoclax which may be used to treat chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or acute myeloid leukemia (AML) Take Venclexta exactly as directed by your healthcare provider, once a day and at approximately the same time each day For most people, the dosage is slowly
  • Patient Guide to Venclexta (Venetoclax) for CLL SLL and AML
    The FDA approved Venclexta for CLL SLL in May 2019 Previously, in 2016, Venclexta was granted accelerated approval for patients with CLL whose cells were missing a portion of chromosome 17, commonly referred to as 17p deletion, and who also received at least one line of prior therapy Accelerated approval is a program that allows for earlier access to drugs that treat serious conditions that
  • Lancet Reviews the Key Treatment Options for BPDCN - Targeted Oncology
    Systemic [therapies] that we’re thinking about that are less intensive include venetoclax [Venclexta], which is a BCL2 inhibitor that has some level of single-agent activity 3 This can be used on occasion if the patient can’t get through more conventional therapy Steroids can be used, and then supportive care is always a mainstay of any
  • A guide to CLL SLL treatment with VENCLEXTA - CLL Society
    VENCLEXTA can cause serious side effects, including tumor lysis syndrome (TLS) TLS can cause kidney failure, the need for dialysis treatment, and may lead to death Your healthcare provider will do tests for TLS It is important to keep your appointments for blood tests Tell your healthcare provider
  • How Its Different - VENCLEXTA® for Untreated CLL SLL
    VENCLEXTA can cause serious side effects, including: Tumor lysis syndrome (TLS) TLS is caused by the fast breakdown of cancer cells TLS can cause kidney failure, the need for dialysis treatment, and may lead to death Your healthcare provider will do tests to check your risk of getting TLS before you start taking VENCLEXTA You will receive
  • Genentech: Venclexta® (venetoclax) - Information for Healthcare Providers
    Withhold VENCLEXTA for Grade 3 and 4 infection until resolution and resume at same or reduced dose Immunization Do not administer live attenuated vaccines prior to, during, or after treatment with VENCLEXTA until B-cell recovery occurs Increased Mortality in Patients with Multiple Myeloma when VENCLEXTA is Added to Bortezomib and
  • Venclexta (venetoclax) - MedicineNet
    Instruct patients to take Venclexta tablets with a meal and water at approximately the same time each day Venclexta tablets should be swallowed whole and not chewed, crushed, or broken prior to swallowing Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Venclexta dosing begins with a 5-week ramp-up Venclexta 5-week Dose Ramp-Up Schedule





中文字典-英文字典  2005-2009